Get the Stockscreener App
0.264
1.69%
+0.0044
After Hours:
.247
-0.017
-6.44%
Mangoceuticals Inc stock is currently priced at $0.264, with a 24-hour trading volume of 60,211.
It has seen a +1.69% increased in the last 24 hours and a +22.85% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.2605 pivot point. If it approaches the $0.2711 resistance level, significant changes may occur.
Previous Close:
$0.2596
Open:
$0.26
24h Volume:
60,211
Market Cap:
$6.50M
Revenue:
-
Net Income/Loss:
$-7.32M
P/E Ratio:
-0.6032
EPS:
-0.4377
Net Cash Flow:
$-5.99M
1W Performance:
+0.34%
1M Performance:
+22.85%
6M Performance:
-55.25%
1Y Performance:
-78.54%
1D Range:
$0.2461
$0.27
52W Range:
$0.143
$2.38
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
214-242-9619
Address
15110 North Dallas Parkway, Suite 600, Dallas
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
GlobeNewswire Inc.
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why Disney Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Benzinga
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
GlobeNewswire Inc.
Mangoceuticals Inc Stock (MGRX) Financials Data
Mangoceuticals Inc (MGRX) Net Income 2024
MGRX net income (TTM) was -$7.32 million for the quarter ending September 30, 2023, a -437.42% decrease year-over-year.
Mangoceuticals Inc (MGRX) Cash Flow 2024
MGRX recorded a free cash flow (TTM) of -$5.99 million for the quarter ending September 30, 2023.
Mangoceuticals Inc (MGRX) Earnings per Share 2024
MGRX earnings per share (TTM) was -$0.524 for the quarter ending September 30, 2023, a -475.82% decline year-over-year.
About Mangoceuticals Inc
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
0.06%
4.53%
Cap:
|
Volume (24h):